Prometheus Biosciences Ownership 2024 | Who Owns Prometheus Biosciences Now?
Institutional Ownership
0.05%
Insider Ownership
16.61%
Retail Ownership
83.34%
Institutional Holders
3.00
Prometheus Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 8.06% | 7.31% | 3,272,104 | -82,199 | -2.45% | 351,162,201,000 | Mar 31, 2023 |
| BLACKROCK INC. | 6.89% | 0.01% | 2,799,818 | -7,886 | -0.28% | 300,476,469,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 6.69% | 0.01% | 2,716,901 | 860,646 | 46.36% | 291,577,814,000 | Mar 31, 2023 |
| BOXER CAPITAL, LLC | 4.67% | 10.00% | 1,897,500 | - | - | 203,640,000 | Mar 31, 2023 |
| 72 INVESTMENT HOLDINGS, LLC | 4.55% | 93.93% | 1,848,024 | - | - | 198,329,936,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 4.07% | 11.70% | 1,655,000 | -435,000 | -20.81% | 177,615,000 | Mar 31, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.61% | 0.49% | 1,465,420 | 199,337 | 15.74% | 157,268,874,000 | Mar 31, 2023 |
| FRED ALGER MANAGEMENT, LLC | 3.28% | 0.76% | 1,331,759 | -27,497 | -2.02% | 142,924,376,000 | Mar 31, 2023 |
| PERCEPTIVE ADVISORS LLC | 3.13% | 4.03% | 1,272,694 | 60,000 | 4.95% | 136,585,520,000 | Mar 31, 2023 |
| STATE STREET CORP | 3.06% | 0.01% | 1,243,571 | -104,609 | -7.76% | 133,460,040,000 | Mar 31, 2023 |
| FMR LLC | 2.82% | 0.01% | 1,146,049 | 391,329 | 51.85% | 122,993,979,000 | Mar 31, 2023 |
| FARALLON CAPITAL MANAGEMENT LLC | 2.71% | 0.67% | 1,100,806 | 955,706 | 658.65% | 118,138,500,000 | Mar 31, 2023 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.54% | 2.64% | 1,031,550 | - | - | 110,705,946,000 | Mar 31, 2023 |
| CHI ADVISORS LLC | 2.30% | 26.61% | 934,135 | 10,335 | 1.12% | 100,251,367,000 | Mar 31, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.18% | 0.01% | 885,332 | 430,273 | 94.55% | 95,015,000 | Mar 31, 2023 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.14% | 0.07% | 868,006 | 3,467 | 0.40% | 93,155,000 | Mar 31, 2023 |
| D. E. SHAW & CO., INC. | 1.96% | 0.09% | 797,567 | 72,338 | 9.97% | 85,594,890,000 | Mar 31, 2023 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.69% | 0.52% | 684,694 | 366,520 | 115.19% | 73,481,360,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.68% | 0.01% | 682,043 | 35,396 | 5.47% | 73,196,892,000 | Mar 31, 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.65% | 1.32% | 670,020 | -362,918 | -35.13% | 71,906,546,000 | Mar 31, 2023 |
Prometheus Biosciences's largest institutional shareholder is RTW INVESTMENTS, LP, holding 8.06% of the company's total share outstanding, currently valued at $351.16B. The top 10 institutional shareholders own together 48.02% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| 72 INVESTMENT HOLDINGS, LLC | 4.55% | 93.93% | 1,848,024 | - | - | 198,329,936,000 | Mar 31, 2023 |
| CHI ADVISORS LLC | 2.30% | 26.61% | 934,135 | 10,335 | 1.12% | 100,251,367,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 4.07% | 11.70% | 1,655,000 | -435,000 | -20.81% | 177,615,000 | Mar 31, 2023 |
| BOXER CAPITAL, LLC | 4.67% | 10.00% | 1,897,500 | - | - | 203,640,000 | Mar 31, 2023 |
| RTW INVESTMENTS, LP | 8.06% | 7.31% | 3,272,104 | -82,199 | -2.45% | 351,162,201,000 | Mar 31, 2023 |
| DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC | 0.37% | 6.49% | 150,000 | -100,000 | -40.00% | 16,098,000,000 | Mar 31, 2023 |
| WAYPOINT CAPITAL ADVISORS, LLC | 0.38% | 5.40% | 154,466 | -16,715 | -9.76% | 16,577,292,000 | Mar 31, 2023 |
| AFFINITY ASSET ADVISORS, LLC | 0.37% | 5.31% | 150,000 | 75,000 | 100.00% | 16,098,000,000 | Mar 31, 2023 |
| PERCEPTIVE ADVISORS LLC | 3.13% | 4.03% | 1,272,694 | 60,000 | 4.95% | 136,585,520,000 | Mar 31, 2023 |
| IKARIAN CAPITAL, LLC | 0.31% | 3.07% | 125,926 | -163,000 | -56.42% | 13,514,378,000 | Mar 31, 2023 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.54% | 2.64% | 1,031,550 | - | - | 110,705,946,000 | Mar 31, 2023 |
| SECTORAL ASSET MANAGEMENT INC | 0.27% | 2.23% | 108,090 | -4,120 | -3.67% | 11,600,219,000 | Mar 31, 2023 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.67% | 2.23% | 272,910 | -10,336 | -3.65% | 29,288,701,000 | Mar 31, 2023 |
| COMMODORE CAPITAL LP | 0.31% | 2.08% | 127,156 | - | - | 13,646,382,000 | Mar 31, 2023 |
| HIGHVISTA STRATEGIES LLC | 0.05% | 1.83% | 20,955 | 1,679 | 8.71% | 2,248,891,000 | Mar 31, 2023 |
| AR ASSET MANAGEMENT INC | 0.12% | 1.46% | 50,414 | -400 | -0.79% | 5,410,000 | Mar 31, 2023 |
| CASDIN CAPITAL, LLC | 0.37% | 1.33% | 150,000 | - | - | 16,098,000,000 | Mar 31, 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.65% | 1.32% | 670,020 | -362,918 | -35.13% | 71,906,546,000 | Mar 31, 2023 |
| TRI LOCUM PARTNERS LP | 0.07% | 0.93% | 28,470 | 28,470 | 100.00% | 3,055,400,000 | Mar 31, 2023 |
| RENAISSANCE CAPITAL LLC | 0.03% | 0.91% | 11,503 | 11,503 | 100.00% | 1,234,502,000 | Mar 31, 2023 |
The largest Prometheus Biosciences shareholder by % of total assets is 72 INVESTMENT HOLDINGS, LLC. The company owns 1.85M shares of Prometheus Biosciences (RXDX), representing 93.93% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 2.71% | 0.67% | 1,100,806 | 955,706 | 658.65% | 118,138,500,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 6.69% | 0.01% | 2,716,901 | 860,646 | 46.36% | 291,577,814,000 | Mar 31, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.18% | 0.01% | 885,332 | 430,273 | 94.55% | 95,015,000 | Mar 31, 2023 |
| FMR LLC | 2.82% | 0.01% | 1,146,049 | 391,329 | 51.85% | 122,993,979,000 | Mar 31, 2023 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.69% | 0.52% | 684,694 | 366,520 | 115.19% | 73,481,360,000 | Mar 31, 2023 |
| DEUTSCHE BANK AG\ | 0.89% | 0.02% | 361,534 | 344,368 | 2006.11% | 38,799,829,000 | Mar 31, 2023 |
| PICTET ASSET MANAGEMENT SA | 0.62% | 0.03% | 251,806 | 248,839 | 8386.89% | 27,023,820,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.96% | 0.00% | 390,276 | 231,910 | 146.44% | 41,884,421,000 | Mar 31, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.49% | 0.07% | 200,000 | 200,000 | 100.00% | 21,464,000,000 | Mar 31, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.61% | 0.49% | 1,465,420 | 199,337 | 15.74% | 157,268,874,000 | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.82% | 0.02% | 331,258 | 192,098 | 138.04% | 35,551,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.93% | 0.00% | 378,016 | 183,559 | 94.40% | 40,568,678,000 | Mar 31, 2023 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.40% | 0.26% | 164,055 | 164,055 | 100.00% | 17,606,000 | Mar 31, 2023 |
| PRINCIPAL FINANCIAL GROUP INC | 0.41% | 0.01% | 167,475 | 157,166 | 1524.55% | 17,973,417,000 | Mar 31, 2023 |
| LORD, ABBETT & CO. LLC | 1.08% | 0.17% | 439,098 | 136,040 | 44.89% | 47,124,000 | Mar 31, 2023 |
| ARTAL GROUP S.A. | 0.30% | 0.78% | 121,756 | 121,756 | 100.00% | 13,067,000 | Mar 31, 2023 |
| POLAR CAPITAL HOLDINGS PLC | 0.23% | 0.07% | 92,500 | 92,500 | 100.00% | 9,927,100,000 | Mar 31, 2023 |
| INVESCO LTD. | 0.89% | 0.01% | 359,749 | 76,603 | 27.05% | 38,608,263,000 | Mar 31, 2023 |
| CAPITAL WORLD INVESTORS | 0.51% | 0.00% | 205,400 | 75,000 | 57.52% | 22,043,528,000 | Mar 31, 2023 |
| AFFINITY ASSET ADVISORS, LLC | 0.37% | 5.31% | 150,000 | 75,000 | 100.00% | 16,098,000,000 | Mar 31, 2023 |
As of Mar 31 2023, Prometheus Biosciences's largest institutional buyer is FARALLON CAPITAL MANAGEMENT LLC. The company purchased 955.71K stocks of RXDX, valued at $118.14B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.04% | 0.10% | 420,706 | -681,133 | -61.82% | 45,150,168,000 | Mar 31, 2023 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -574,200 | -100.00% | - | Mar 31, 2023 |
| CAPTION MANAGEMENT, LLC | - | - | - | -552,300 | -100.00% | - | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 4.07% | 11.70% | 1,655,000 | -435,000 | -20.81% | 177,615,000 | Mar 31, 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.65% | 1.32% | 670,020 | -362,918 | -35.13% | 71,906,546,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.51% | 0.00% | 208,100 | -268,300 | -56.32% | 22,333,292,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.04% | 0.01% | 14,200 | -239,200 | -94.40% | 1,523,944,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.16% | 0.00% | 66,300 | -232,900 | -77.84% | 7,115,316,000 | Mar 31, 2023 |
| JANE STREET GROUP, LLC | 0.25% | 0.00% | 99,900 | -210,900 | -67.86% | 10,721,268,000 | Mar 31, 2023 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -204,000 | -100.00% | - | Mar 31, 2023 |
| FRANKLIN RESOURCES INC | 0.67% | 0.01% | 273,810 | -188,038 | -40.71% | 29,385,289,000 | Mar 31, 2023 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -172,400 | -100.00% | - | Mar 31, 2023 |
| GOLDMAN SACHS GROUP INC | 0.50% | 0.00% | 204,858 | -164,266 | -44.50% | 21,985,361,000 | Mar 31, 2023 |
| IKARIAN CAPITAL, LLC | 0.31% | 3.07% | 125,926 | -163,000 | -56.42% | 13,514,378,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.19% | 0.00% | 75,600 | -141,600 | -65.19% | 8,113,392,000 | Mar 31, 2023 |
| CAPTION MANAGEMENT, LLC | 0.09% | 0.07% | 35,000 | -115,200 | -76.70% | 3,756,200,000 | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | 0.14% | 0.02% | 54,988 | -107,846 | -66.23% | 5,901,312,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.10% | 0.00% | 39,900 | -105,100 | -72.48% | 4,282,000 | Mar 31, 2023 |
| STATE STREET CORP | 3.06% | 0.01% | 1,243,571 | -104,609 | -7.76% | 133,460,040,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.04% | 0.01% | 15,600 | -104,100 | -86.97% | 1,674,192,000 | Mar 31, 2023 |
As of Mar 31 2023, Prometheus Biosciences's biggest institutional seller is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company sold -0.68M shares of RXDX, valued at $45.15B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 0.49% | 0.07% | 200,000 | 200,000 | 100.00% | 21,464,000,000 | Mar 31, 2023 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.40% | 0.26% | 164,055 | 164,055 | 100.00% | 17,606,000 | Mar 31, 2023 |
| ARTAL GROUP S.A. | 0.30% | 0.78% | 121,756 | 121,756 | 100.00% | 13,067,000 | Mar 31, 2023 |
| POLAR CAPITAL HOLDINGS PLC | 0.23% | 0.07% | 92,500 | 92,500 | 100.00% | 9,927,100,000 | Mar 31, 2023 |
| AMUNDI | 0.16% | 0.00% | 65,989 | 65,989 | 100.00% | 7,165,086,000 | Mar 31, 2023 |
| MAN GROUP PLC | 0.14% | 0.02% | 57,959 | 57,959 | 100.00% | 6,220,160,000 | Mar 31, 2023 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 0.09% | 0.00% | 37,339 | 37,339 | 100.00% | 4,007,221,000 | Mar 31, 2023 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 0.09% | 0.01% | 34,592 | 34,592 | 100.00% | 3,712,413,000 | Mar 31, 2023 |
| HAP TRADING, LLC | 0.07% | 0.01% | 30,400 | 30,400 | 100.00% | 33,000 | Mar 31, 2023 |
| TRI LOCUM PARTNERS LP | 0.07% | 0.93% | 28,470 | 28,470 | 100.00% | 3,055,400,000 | Mar 31, 2023 |
| J. GOLDMAN & CO LP | 0.07% | 0.12% | 27,000 | 27,000 | 100.00% | 2,897,640,000 | Mar 31, 2023 |
| CITIGROUP INC | 0.06% | 0.00% | 25,000 | 25,000 | 100.00% | 2,683,000,000 | Mar 31, 2023 |
| CITIGROUP INC | 0.06% | 0.00% | 25,000 | 25,000 | 100.00% | 2,683,000,000 | Mar 31, 2023 |
| CHI ADVISORS LLC | 0.06% | 0.03% | 25,000 | 25,000 | 100.00% | 108,125,000 | Mar 31, 2023 |
| TANG CAPITAL MANAGEMENT LLC | 0.05% | 0.34% | 21,000 | 21,000 | 100.00% | 2,253,720,000 | Mar 31, 2023 |
| MOORE CAPITAL MANAGEMENT, LP | 0.05% | 0.05% | 20,381 | 20,381 | 100.00% | 2,187,289,000 | Mar 31, 2023 |
| J. GOLDMAN & CO LP | 0.05% | 0.09% | 20,301 | 20,301 | 100.00% | 2,178,703,000 | Mar 31, 2023 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 0.05% | 0.01% | 19,932 | 19,932 | 100.00% | 2,139,102,000 | Mar 31, 2023 |
| TWINBEECH CAPITAL LP | 0.05% | 0.04% | 18,546 | 18,546 | 100.00% | 1,990,357,000 | Mar 31, 2023 |
| CENTERBOOK PARTNERS LP | 0.03% | 0.21% | 13,702 | 13,702 | 100.00% | 1,470,499,000 | Mar 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | 0.03% | 0.00% | 12,946 | 12,946 | 100.00% | 1,389,365,000 | Mar 31, 2023 |
| JEFFERIES FINANCIAL GROUP INC. | 0.03% | 0.01% | 12,565 | 12,565 | 100.00% | 1,348,476,000 | Mar 31, 2023 |
| RENAISSANCE CAPITAL LLC | 0.03% | 0.91% | 11,503 | 11,503 | 100.00% | 1,234,502,000 | Mar 31, 2023 |
| PROFUND ADVISORS LLC | 0.03% | 0.08% | 11,488 | 11,488 | 100.00% | 1,232,892,000 | Mar 31, 2023 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.02% | 0.03% | 9,348 | 9,348 | 100.00% | 1,003,227,000 | Mar 31, 2023 |
| ALGERT GLOBAL LLC | 0.02% | 0.04% | 7,220 | 7,220 | 100.00% | 775,000 | Mar 31, 2023 |
| SUPPLEMENTAL ANNUITY COLLECTIVE TRUST OF NJ | 0.01% | 0.25% | 6,000 | 6,000 | 100.00% | 643,920,000 | Mar 31, 2023 |
| JEFFERIES FINANCIAL GROUP INC. | 0.01% | 0.00% | 5,600 | 5,600 | 100.00% | 600,992,000 | Mar 31, 2023 |
| MIRABELLA FINANCIAL SERVICES LLP | 0.01% | 0.19% | 5,198 | 5,198 | 100.00% | 1,257,950,000 | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | 0.01% | 0.05% | 3,949 | 3,949 | 100.00% | 424,000 | Mar 31, 2023 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.01% | 0.05% | 3,672 | 3,672 | 100.00% | 394,079,000 | Mar 31, 2023 |
| BLUESHIFT ASSET MANAGEMENT, LLC | 0.01% | 0.15% | 3,363 | 3,363 | 100.00% | 360,917,000 | Mar 31, 2023 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0.01% | 0.00% | 3,270 | 3,270 | 100.00% | 351,000 | Mar 31, 2023 |
| ENGINEERS GATE MANAGER LP | 0.01% | 0.01% | 3,255 | 3,255 | 100.00% | 349,327,000 | Mar 31, 2023 |
| SEA OTTER ADVISORS LLC | 0.01% | 0.16% | 3,000 | 3,000 | 100.00% | 321,960,000 | Mar 31, 2023 |
| MARTINGALE ASSET MANAGEMENT L P | 0.01% | 0.01% | 2,849 | 2,849 | 100.00% | 305,755,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.01% | 0.00% | 2,421 | 2,421 | 100.00% | 259,822,000 | Mar 31, 2023 |
| HARBOR CAPITAL ADVISORS, INC. | 0.01% | 0.07% | 2,099 | 2,099 | 100.00% | 225,265,000 | Mar 31, 2023 |
| WALLEYE TRADING LLC | 0.00% | 0.00% | 1,700 | 1,700 | 100.00% | 182,444,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.00% | 0.00% | 758 | 758 | 100.00% | 81,000 | Mar 31, 2023 |
| WALLEYE TRADING LLC | 0.00% | 0.00% | 700 | 700 | 100.00% | 75,124,000 | Mar 31, 2023 |
| ASSETMARK, INC | 0.00% | 0.00% | 379 | 379 | 100.00% | 40,674,000 | Mar 31, 2023 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 365 | 365 | 100.00% | 39,172,000 | Mar 31, 2023 |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 10,732,000 | Mar 31, 2023 |
| QUADRANT CAPITAL GROUP LLC | 0.00% | 0.00% | 73 | 73 | 100.00% | 7,835,000 | Mar 31, 2023 |
| COVESTOR LTD | 0.00% | 0.01% | 72 | 72 | 100.00% | 8,000 | Mar 31, 2023 |
| ALLWORTH FINANCIAL LP | 0.00% | 0.00% | 66 | 66 | 100.00% | 7,084,000 | Mar 31, 2023 |
| WALLEYE TRADING LLC | 0.00% | - | 58 | 58 | 100.00% | 6,225,000 | Mar 31, 2023 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | 0.00% | 10 | 10 | 100.00% | 1,073,000 | Mar 31, 2023 |
| BOGART WEALTH, LLC | - | 0.00% | 7 | 7 | 100.00% | 751,000 | Mar 31, 2023 |
Prometheus Biosciences's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 200.00K shares, valued at $21.46B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -574,200 | -100.00% | - | Mar 31, 2023 |
| CAPTION MANAGEMENT, LLC | - | - | - | -552,300 | -100.00% | - | Mar 31, 2023 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -204,000 | -100.00% | - | Mar 31, 2023 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -172,400 | -100.00% | - | Mar 31, 2023 |
| IKARIAN CAPITAL, LLC | - | - | - | -100,000 | -100.00% | - | Mar 31, 2023 |
| DARWIN GLOBAL MANAGEMENT, LTD. | - | - | - | -91,379 | -100.00% | - | Mar 31, 2023 |
| CAPTION MANAGEMENT, LLC | - | - | - | -81,209 | -100.00% | - | Mar 31, 2023 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -75,000 | -100.00% | - | Mar 31, 2023 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -58,070 | -100.00% | - | Mar 31, 2023 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -50,000 | -100.00% | - | Mar 31, 2023 |
| MARSHALL WACE, LLP | - | - | - | -48,777 | -100.00% | - | Mar 31, 2023 |
| JUMP FINANCIAL, LLC | - | - | - | -36,120 | -100.00% | - | Mar 31, 2023 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -35,700 | -100.00% | - | Mar 31, 2023 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -31,100 | -100.00% | - | Mar 31, 2023 |
| EAM INVESTORS, LLC | - | - | - | -30,504 | -100.00% | - | Mar 31, 2023 |
| TRI LOCUM PARTNERS LP | - | - | - | -25,700 | -100.00% | - | Mar 31, 2023 |
| TREXQUANT INVESTMENT LP | - | - | - | -23,816 | -100.00% | - | Mar 31, 2023 |
| EAM GLOBAL INVESTORS LLC | - | - | - | -22,893 | -100.00% | - | Mar 31, 2023 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -22,321 | -100.00% | - | Mar 31, 2023 |
| PARALLAX VOLATILITY ADVISERS, L.P. | - | - | - | -22,100 | -100.00% | - | Mar 31, 2023 |
| PURA VIDA INVESTMENTS, LLC | - | - | - | -21,000 | -100.00% | - | Mar 31, 2023 |
| SEVEN GRAND MANAGERS, LLC | - | - | - | -20,105 | -100.00% | - | Mar 31, 2023 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -20,100 | -100.00% | - | Mar 31, 2023 |
| ROKOS CAPITAL MANAGEMENT LLP | - | - | - | -20,000 | -100.00% | - | Mar 31, 2023 |
| GHISALLO CAPITAL MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Mar 31, 2023 |
| FORA CAPITAL, LLC | - | - | - | -16,177 | -100.00% | - | Mar 31, 2023 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -15,000 | -100.00% | - | Mar 31, 2023 |
| CAAS CAPITAL MANAGEMENT LP | - | - | - | -15,000 | -100.00% | - | Mar 31, 2023 |
| SEVEN EIGHT CAPITAL, LP | - | - | - | -12,627 | -100.00% | - | Mar 31, 2023 |
| PURA VIDA INVESTMENTS, LLC | - | - | - | -12,500 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2023 |
| CSS LLC/IL | - | - | - | -9,400 | -100.00% | - | Mar 31, 2023 |
| CONNECTIVE PORTFOLIO MANAGEMENT, LLC | - | - | - | -9,000 | -100.00% | - | Mar 31, 2023 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -7,600 | -100.00% | - | Mar 31, 2023 |
| PENTWATER CAPITAL MANAGEMENT LP | - | - | - | -6,000 | -100.00% | - | Mar 31, 2023 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -5,623 | -100.00% | - | Mar 31, 2023 |
| OVERSEA-CHINESE BANKING CORP LTD | - | - | - | -5,442 | -100.00% | - | Mar 31, 2023 |
| PENTWATER CAPITAL MANAGEMENT LP | - | - | - | -5,000 | -100.00% | - | Mar 31, 2023 |
| WEXFORD CAPITAL LP | - | - | - | -4,506 | -100.00% | - | Mar 31, 2023 |
| UBS OCONNOR LLC | - | - | - | -4,500 | -100.00% | - | Mar 31, 2023 |
| QUANTAMENTAL TECHNOLOGIES LLC | - | - | - | -4,287 | -100.00% | - | Mar 31, 2023 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -4,102 | -100.00% | - | Mar 31, 2023 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -3,345 | -100.00% | - | Mar 31, 2023 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | - | - | - | -3,128 | -100.00% | - | Mar 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -2,806 | -100.00% | - | Mar 31, 2023 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -2,200 | -100.00% | - | Mar 31, 2023 |
| CSS LLC/IL | - | - | - | -1,500 | -100.00% | - | Mar 31, 2023 |
| CSS LLC/IL | - | - | - | -1,500 | -100.00% | - | Mar 31, 2023 |
| MONEY CONCEPTS CAPITAL CORP | - | - | - | -647 | -100.00% | - | Mar 31, 2023 |
| SANDIA INVESTMENT MANAGEMENT LP | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | - | - | - | -39 | -100.00% | - | Mar 31, 2023 |
| COMERICA SECURITIES,INC. | - | - | - | -6 | -100.00% | - | Mar 31, 2023 |
Prometheus Biosciences's largest sold out institutional shareholder by shares sold is SIO CAPITAL MANAGEMENT, LLC, sold -0.57M shares, valued at -, as of undefined.
Prometheus Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER FUNDS II | 1.08% | 244,749 | - | - | Jan 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.56% | 146,537 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.44% | 423,981 | - | - | Jan 31, 2024 |
| Alger ETF Trust | 0.12% | 859 | - | - | Dec 31, 2023 |
| ALGER PORTFOLIOS | 0.11% | 41,355 | - | - | Dec 31, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.07% | 68,793 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.07% | 266,246 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.07% | 169,710 | - | - | Jan 31, 2024 |
| AltShares Trust | 0.06% | 11,635 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 26,415 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.05% | 21,837 | - | - | Mar 31, 2024 |
| Gabelli 787 Fund, Inc. | 0.04% | 3,500 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.04% | 84,104 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.03% | 28,701 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.03% | 105,265 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.03% | 158,437 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.03% | 83,554 | - | - | Mar 31, 2024 |
| Comstock Funds, Inc. | 0.03% | 600 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.03% | 6,920 | - | - | Mar 31, 2024 |
| ARBITRAGE FUNDS | 0.02% | 107,239 | - | - | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.02% | 379,325 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.02% | 144,142 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 149,381 | - | - | Jan 31, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.02% | 11,503 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 133,125 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 43,642 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.01% | 5,150 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 286,175 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.01% | 92,725 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,355 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 55,298 | - | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.01% | 142,681 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 397,555 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,342,882 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 13,756 | - | - | Feb 29, 2024 |
| BARON SELECT FUNDS | 0.00% | 42,750 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 34,904 | - | - | Mar 28, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.00% | 2,417 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 792 | - | - | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.00% | 98,684 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.00% | 205,400 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 31,506 | - | - | Feb 29, 2024 |
| PIONEER SERIES TRUST II | 0.00% | 28,131 | - | - | Feb 29, 2024 |
| Federated Hermes Adviser Series | 0.00% | 14,276 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 94,095 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 66,700 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 12,975 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 19,364 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 145,486 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 7,287 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 307,921 | - | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,030 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 5,813 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,784 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.00% | 21 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,588 | - | - | Mar 31, 2024 |
| AMG Funds I | 0.00% | 1,842 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 5,550 | - | - | Aug 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 24,096 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 21,680 | - | - | Dec 31, 2023 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 7,106 | - | - | Feb 29, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 56,364 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 802 | - | - | Dec 31, 2023 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 2,975 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 12,336 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 936 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 7,568 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 47,288 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,842 | - | - | Mar 31, 2024 |
| AMG FUNDS | 0.00% | 13,800 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 10,339 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,144 | - | - | Mar 31, 2024 |
| SEI Catholic Values Trust | 0.00% | 1,081 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,241 | - | - | Mar 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 41,804 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 60,727 | - | - | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 87,192 | - | - | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,349 | - | - | Mar 31, 2024 |
| AB PORTFOLIOS | 0.00% | 5,726 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 162,696 | - | - | Feb 29, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 9,178 | - | - | Jan 31, 2024 |
| NEUBERGER BERMAN ALTERNATIVE FUNDS | 0.00% | 3,246 | - | - | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 223 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 1,325 | - | - | Mar 31, 2024 |
| Harbor ETF Trust | 0.00% | 1,082 | - | - | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 3,176 | - | - | Feb 29, 2024 |
| CREDIT SUISSE OPPORTUNITY FUNDS | 0.00% | 9,638 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 999 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 11,241 | - | - | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 1,039 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 23,225 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 46,693 | - | - | Feb 29, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 6,500 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 256 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 670,020 | - | - | Mar 31, 2024 |
| PIONEER VARIABLE CONTRACTS TRUST /MA/ | 0.00% | 3,379 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,400 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 38,247 | - | - | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 2,331 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 454 | - | - | Dec 31, 2023 |
Prometheus Biosciences's largest mutual fund holder by % of total assets is "ALGER FUNDS II", owning 244.75K shares, compromising 1.08% of its total assets.
Prometheus Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 23 | 3 | -98.74% |
| 31 Mar, 23 | 239 | -1.65% |
| 31 Dec, 22 | 243 | 58.82% |
| 30 Sep, 22 | 153 | 28.57% |
| 30 Jun, 22 | 119 | 13.33% |
| 31 Mar, 22 | 105 | 32.91% |
| 31 Dec, 21 | 79 | 54.90% |
| 30 Sep, 21 | 51 | 4.08% |
| 30 Jun, 21 | 49 | 19.51% |
| 31 Mar, 21 | 41 | - |
As of 30 Jun 23, 3 institutions are holding Prometheus Biosciences's shares, representing a decrease of -98.74% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 23 | 25,622 | -99.94% |
| 31 Mar, 23 | 40,539,567 | 6.56% |
| 31 Dec, 22 | 38,044,843 | 15.85% |
| 30 Sep, 22 | 32,840,243 | 6.63% |
| 30 Jun, 22 | 30,799,709 | 11.39% |
| 31 Mar, 22 | 27,651,342 | 8.12% |
| 31 Dec, 21 | 25,574,912 | 5.28% |
| 30 Sep, 21 | 24,292,976 | 0.50% |
| 30 Jun, 21 | 24,172,978 | -0.30% |
| 31 Mar, 21 | 24,245,109 | - |
Prometheus Biosciences (RXDX) has 25.62K shares outstanding as of 30 Jun 23, down -99.94% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 23 | 0.05% | 0.00% |
| 31 Mar, 23 | 85.42% | 1.09% |
| 31 Dec, 22 | 88.58% | 1.40% |
| 30 Sep, 22 | 79.67% | 1.29% |
| 30 Jun, 22 | 78.48% | 1.56% |
| 31 Mar, 22 | 70.89% | 1.64% |
| 31 Dec, 21 | 65.72% | 1.68% |
| 30 Sep, 21 | 62.53% | 1.61% |
| 30 Jun, 21 | 62.28% | 1.27% |
| 31 Mar, 21 | 70.06% | - |
As of 30 Jun 23, Prometheus Biosciences is held by 0.05% institutional shareholders, representing a 0.00% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 23 | - | -100.00% |
| 31 Mar, 23 | 131 | -22.49% |
| 31 Dec, 22 | 169 | 72.45% |
| 30 Sep, 22 | 98 | 48.48% |
| 30 Jun, 22 | 66 | 11.86% |
| 31 Mar, 22 | 59 | -10.61% |
| 31 Dec, 21 | 66 | 164.00% |
| 30 Sep, 21 | 25 | -19.35% |
| 30 Jun, 21 | 31 | -24.39% |
| 31 Mar, 21 | 41 | - |
- institutional shareholders have increased their position in RXDX stock as of 30 Jun 23 compared to 131 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 23 | - | -100.00% |
| 31 Mar, 23 | 74 | 57.45% |
| 31 Dec, 22 | 47 | 56.67% |
| 30 Sep, 22 | 30 | -16.67% |
| 30 Jun, 22 | 36 | 20.00% |
| 31 Mar, 22 | 30 | 500.00% |
| 31 Dec, 21 | 5 | -61.54% |
| 30 Sep, 21 | 13 | 30.00% |
| 30 Jun, 21 | 10 | - |
| 31 Mar, 21 | - | - |
- institutional shareholders have reduced their position in RXDX stock as of 30 Jun 23 compared to 74 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 23 | 3 | -98.74% | 25,622 | -99.94% | 0.05% | 0.00% | - | -100.00% | - | -100.00% |
| 31 Mar, 23 | 239 | -1.65% | 40,539,567 | 6.56% | 85.42% | 1.09% | 131 | -22.49% | 74 | 57.45% |
| 31 Dec, 22 | 243 | 58.82% | 38,044,843 | 15.85% | 88.58% | 1.40% | 169 | 72.45% | 47 | 56.67% |
| 30 Sep, 22 | 153 | 28.57% | 32,840,243 | 6.63% | 79.67% | 1.29% | 98 | 48.48% | 30 | -16.67% |
| 30 Jun, 22 | 119 | 13.33% | 30,799,709 | 11.39% | 78.48% | 1.56% | 66 | 11.86% | 36 | 20.00% |
| 31 Mar, 22 | 105 | 32.91% | 27,651,342 | 8.12% | 70.89% | 1.64% | 59 | -10.61% | 30 | 500.00% |
| 31 Dec, 21 | 79 | 54.90% | 25,574,912 | 5.28% | 65.72% | 1.68% | 66 | 164.00% | 5 | -61.54% |
| 30 Sep, 21 | 51 | 4.08% | 24,292,976 | 0.50% | 62.53% | 1.61% | 25 | -19.35% | 13 | 30.00% |
| 30 Jun, 21 | 49 | 19.51% | 24,172,978 | -0.30% | 62.28% | 1.27% | 31 | -24.39% | 10 | - |
| 31 Mar, 21 | 41 | - | 24,245,109 | - | 70.06% | - | 41 | - | - | - |
Prometheus Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Prometheus Biosciences's stock was made by Hendrix Martin on Jun 16 2023, selling 2,071 shares at $200.00 per share (valued at $414.20K).
Prometheus Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | 13 | 56 | 23.21% |
| Q1 2023 | 10 | 21 | 47.62% |
| Q4 2022 | 7 | - | - |
| Q2 2022 | 10 | 1 | 1000.00% |
| Q4 2021 | 9 | 1 | 900.00% |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 3 | - | - |
| Q1 2021 | 21 | 46 | 45.65% |
13 total buy trades, and 56 total sell trades (buy/sell ratio of 0.23%) were made by Prometheus Biosciences's insiders, as of Q2 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 11 | - |
| Q4 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 7 | - | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Prometheus Biosciences's stocks.
Prometheus Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| ROIV | Roivant Sciences Ltd. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| VKTX | Viking Therapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| KRYS | Krystal Biotech, Inc. |
| IMVT | Immunovant, Inc. |
| ETNB | 89bio, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
RXDX Ownership FAQ
Who Owns Prometheus Biosciences?
Prometheus Biosciences is owned by institutional shareholders (0.05%), insiders (16.61%), and public (83.34%). The largest institutional shareholder of Prometheus Biosciences is RTW INVESTMENTS, LP (8.06% of total shares) and the top mutual fund owner is ALGER FUNDS II (1.08% of total shares).
Who are the major institutional shareholders of Prometheus Biosciences?
Prometheus Biosciences's major institutional shareholders are RTW INVESTMENTS, LP, BLACKROCK INC., VANGUARD GROUP INC, BOXER CAPITAL, LLC, and 72 INVESTMENT HOLDINGS, LLC. The top five shareholders own together 30.86% of the company's share outstanding.
How many Prometheus Biosciences shareholders are there?
As of Jun 2023, there are 3 institutional shareholders of Prometheus Biosciences.
What percentage of Prometheus Biosciences is owned by RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP owns 3.27M shares of Prometheus Biosciences, representing 8.06% of the company's total shares outstanding, valued at $351.16B (as of Mar 2023).
What percentage of Prometheus Biosciences is owned by BLACKROCK INC?
As of Mar 2023, BLACKROCK INC holds 2.8M shares of Prometheus Biosciences (RXDX), compromising 6.89% of the company, valued at $300.48B.
What percentage of Prometheus Biosciences is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Prometheus Biosciences. The company owns 2.72M of the company's shares outstanding (worth $291.58B).